SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Sdgla who wrote (1217668)4/6/2020 6:32:24 PM
From: J_F_Shepard  Read Replies (1) | Respond to of 1574595
 
The drug is out of patent and saving lives.


Let's see what you've got on it......



To: Sdgla who wrote (1217668)4/7/2020 6:37:48 AM
From: Taro2 Recommendations

Recommended By
locogringo
Winfastorlose

  Respond to of 1574595
 
The drug was invented and introduced to the market by Bayer AG in 1934. Since their patents are long expired, as a generic drug it has been available from Bayer and others at very low cost. Interesting, however, after so many years Bayer suddenly pulled their version, the Resorchin 200mg from the market September 2019 ... (Why sell at low prices if you expect demand to sky-rocket?).


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News